INTELLIA THERAPEUTICS INC (NTLA) Stock Cash Flow
NASDAQ:NTLA • US45826J1051
11.87 USD
+0.25 (+2.15%)
At close: Feb 13, 2026
11.89 USD
+0.02 (+0.17%)
After Hours: 2/13/2026, 8:00:01 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -445.81M | -519.02M | -481.19M | -474.19M | -267.89M | |||
| Depreciation Amortization | 9.95M | 10.29M | 8.98M | 7.57M | 6.89M | |||
| Change In Working Capital | -72.21M | 11.88M | -52.45M | -53.87M | -22.90M | |||
| Other non cash items | 97.41M | 147.98M | 130.58M | 187.20M | 58.88M | |||
| OPERATING CASH FLOW | -410.65M | -348.88M | -394.09M | -333.29M | -225.03M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.98M | -5.78M | -13.98M | -13.56M | -12.76M | |||
| Other Investing Activity | 354.05M | 131.34M | -17.36M | 173.87M | -538.02M | |||
| INVESTING CASH FLOW | 352.06M | 125.57M | -31.35M | 160.31M | -550.78M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 131.83M | 185.75M | 130.32M | 582.96M | 736.69M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 131.83M | 185.75M | 130.32M | 582.96M | 736.69M | |||
| CHANGE IN CASH | 73.24M | -37.57M | -295.11M | 409.98M | -39.12M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -410.65M | -348.88M | -394.09M | -333.29M | -225.03M | |||
| Capital Expenditure | -1.98M | -5.78M | -13.98M | -13.56M | -12.76M | |||
| FREE CASH FLOW | -412.63M | -354.66M | -408.07M | -346.85M | -237.79M | |||
All data in USD